Sarda Proteins Resubmits Financial Results Due to Clerical Errors

Sarda Proteins Ltd has resubmitted its audited financial results for the quarter and financial year ended March 31, 2026. The revision was necessitated by clerical errors related to the booking of interest income and the reclassification of share warrants as equity. The company assures that these corrections are purely clerical and have no material impact on the overall financial position. The revised outcome of the Board Meeting and financial results replace the earlier submission made on April 30, 2026. The Board Meeting took place from 4:30 PM to 5:15 PM.